To date, there have been 2 NDAs (drugs), 10 PMAs (devices) and 1 510k (devices) approved by FDA that used Target e*CRF® as the EDC tool. This week one of our clients announced the submission of their first BLA (Biologics License Application). This is the 2nd FDA submission this year that used Target e*CRF® (EDC); a PMA was submitted in January. An NDA being prepared by Target Health will be submitted this month.

Target Health will also be displaying at the annual DIA meeting in Atlanta. This year we will be showcasing Target e*CRF® Version 3.1 (technology transfer with no code writing) and Target Document™ as well as our overall eCRO capabilities. Private showings will also be available. Visit us at Booth 137.

For more information about Target Health, please contact Dr. Jules T. Mitchel.